The Clinical Utility of Droplet Digital Polymerase Chain Reaction (PCR): A Breakthrough for Cancer and Noninvasive Prenatal Genetic Disease Diagnosis.

Published 03/24/2026

Research record: The Clinical Utility of Droplet Digital Polymerase Chain Reaction (PCR): A Breakthrough for Cancer and Noninvasive Prenatal Genetic Disease Diagnosis.

Published in Cureus; first publication date 2026-03-24. PMID 42037945.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-03-24

Updated

2026-10-20

Disclaimer

professional use

References